These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 4121179

  • 1. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG, May J, Rogers JH, Storey BG, Katran DC, Duggin GG, Johnson JR, Stewart JH.
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract] [Full Text] [Related]

  • 2. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG, Mears D, Kelly GE, Stewart JH, Johnson JR, Tiller D, Gallery ED, Duggin GG.
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP, Codish SD.
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [Abstract] [Full Text] [Related]

  • 11. Use of antithymocyte globulin in human heart transplantation.
    Griepp RB, Stinson EB, Dong E, Phillips RC, Morrell RM, Shumway NE.
    Circulation; 1972 May; 45(5 Suppl 1):I147-53. PubMed ID: 4554349
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ULF ballistocardiography in human cardiac transplantation.
    Shakespeare T, Reitan JA, Smith NT, Stinson EB, Shumway NE.
    Bibl Cardiol; 1971 May; ():Suppl 27:1-9. PubMed ID: 4935282
    [No Abstract] [Full Text] [Related]

  • 17. Clinical aspects of allograft rejection.
    Williams GM.
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract] [Full Text] [Related]

  • 18. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM, Sterioff S, Bias W.
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract] [Full Text] [Related]

  • 19. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 20. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts.
    MacDonald AS, Alexander JL, Busch GJ, Murray JE.
    Surg Forum; 1969 Feb; 20():306-7. PubMed ID: 4192215
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.